Yucheng Xu

973 citations
45 papers · 686 indexed · h-index 15
Topics
Cancer Cells and Metastasis (7 papers)Cancer Genomics and Diagnostics (6 papers)Prostate Cancer Treatment and Research (5 papers)
Journals
Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Yucheng Xu

41 papers receiving 682 citations

Peers

Yucheng Xu
Comparison fields: 5 of 117
  • Molecular Biology 286
  • Physiology 117
  • Rheumatology 90
  • Oncology 76
  • Infectious Diseases 62
Replace Jovana Maksimovic with:
Jovana Maksimovic Australia
Annika Janson Sweden
Laura Graham United States
Akiko Ohta Japan
Shirin Kalyan Canada
Sarah Johnson United States
Chandrakant Tayade Canada
Johannes Hain Germany
Deepak Modi India
Jean H. Priest United States
Yucheng Xu relative to Jovana Maksimovic Australia Jovana Maksimovic's profile →
Citations per field
00.5×1.5×2.4×
Jovana Maksimovic · 1×
Citations per year

Countries citing papers authored by Yucheng Xu

Since Specialization
Citations

This map shows the geographic impact of Yucheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yucheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yucheng Xu more than expected).

Fields of papers citing papers by Yucheng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yucheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yucheng Xu. The network helps show where Yucheng Xu may publish in the future.

Co-authorship network of co-authors of Yucheng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yucheng Xu. A scholar is included among the top collaborators of Yucheng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yucheng Xu. Yucheng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 7
5 5
6 23
7 3
8 8
9 13
10 4
11 57
12 8
13 4
14 19
15 5
16 4
17 23
18 10
19 17
20 33

About Yucheng Xu

Yucheng Xu is a scholar working on Gastroenterology, Aging and Cancer Research, having authored 45 papers that have together received 686 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Cancer Genomics and Diagnostics (6 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Aging (12 citations), Health (52 citations) and Rheumatology (90 citations). Yucheng Xu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Amir Goldkorn, Malcolm L. Snead, Kaijie He, Yan Zhou, Tong Xu, Michaël Kahn, Ormond A. MacDougald, Alexander Ring, Wei Lin and Jingjie Fan. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026